Application of immunosuppressants after liver transplantation for hepatocellular carcinoma
DOI:10.3969/j.issn.1001-5256.2021.02.005
- VernacularTitle:肝细胞癌肝移植术后免疫抑制剂的应用
- Author:
Yang YANG
1
;
Yinan DENG
Author Information
1. Center of Liver Transplantation, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China
- Publication Type:Research Article
- Keywords:
Carcinoma, Hepatocellular;
Liver Transplantation;
Immunosuppressive Agents;
Graft Rejection;
Neoplasm Recurrence, Local
- From:
Journal of Clinical Hepatology
2021;37(2):263-266
- CountryChina
- Language:Chinese
-
Abstract:
Liver transplantation has become an important method for radical treatment of hepatocellular carcinoma (HCC), but postoperative recurrence and metastasis severely limit the efficacy of liver transplantation for HCC. In recent years, scholars in China and globally have conducted a series of studies on the association of the application of immunosuppressants after liver transplantation with the recurrence and metastasis of HCC. This article briefly introduces the strategies and suggestions for the clinical application of immunosuppressants after liver transplantation for HCC, in order to provide guidance for clinical practice.
